QCG
GSK icon

Quadrant Capital Group’s GSK GSK Stock Holding History

Quadrant Capital Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.77M Buy
50,151
+999
+2% +$54.1K 0.08% 195
2025
Q4 		$2.41M Buy
49,152
+9,552
+24% +$446K 0.07% 214
2025
Q3 		$1.71M Sell
39,600
-22,482
-36% -$878K 0.06% 298
2025
Q2 		$2.38M Buy
62,082
+5,183
+9% +$198K 0.09% 191
2025
Q1 		$2.2M Buy
56,899
+41,013
+258% +$1.5M 0.08% 163
2024
Q4 		$537K Sell
15,886
-370
-2% -$13.3K 0.04% 310
2024
Q3 		$665K Buy
16,256
+798
+5% +$32.6K 0.05% 278
2024
Q2 		$595K Sell
15,458
-1,872
-11% -$78.7K 0.04% 284
2024
Q1 		$743K Buy
17,330
+601
+4% +$24.8K 0.06% 239
2023
Q4 		$620K Sell
16,729
-46
-0.3% -$1.65K 0.05% 256
2023
Q3 		$608K Buy
16,775
+2,845
+20% +$101K 0.06% 230
2023
Q2 		$497K Sell
13,930
-773
-5% -$27.7K 0.05% 260
2023
Q1 		$523K Buy
14,703
+650
+5% +$22.7K 0.05% 258
2022
Q4 		$494K Buy
14,053
+10,320
+276% +$344K 0.06% 240
2022
Q3 		$110K Sell
3,733
-5,773
-61% -$219K 0.01% 648
2022
Q2 		$517K Buy
9,506
+2,245
+31% +$124K 0.07% 212
2022
Q1 		$395K Buy
7,261
+525
+8% +$28.5K 0.05% 278
2021
Q4 		$371K Sell
6,736
-378
-5% -$19.7K 0.04% 288
2021
Q3 		$340K Buy
7,114
+1,081
+18% +$54.3K 0.05% 263
2021
Q2 		$300K Buy
6,033
+800
+15% +$38.4K 0.04% 282
2021
Q1 		$233K Buy
5,233
+1,461
+39% +$66.3K 0.04% 312
2020
Q4 		$174K Sell
3,772
-1,943
-34% -$89.3K 0.03% 343
2020
Q3 		$269K Buy
5,715
+1,717
+43% +$86K 0.06% 207
2020
Q2 		$204K Sell
3,998
-22,468
-85% -$1.15M 0.05% 270
2020
Q1 		$1.25M Buy
26,466
+2,092
+9% +$112K 0.21% 84
2019
Q4 		$1.41M Buy
24,374
+1,861
+8% +$104K 0.17% 98
2019
Q3 		$1.19M Buy
22,513
+380
+2% +$19.5K 0.18% 90
2019
Q2 		$1.09M Buy
22,133
+4,375
+25% +$220K 0.17% 92
2019
Q1 		$910K Buy
17,758
+3,940
+29% +$197K 0.16% 103
2018
Q4 		$649K Buy
13,818
+9,834
+247% +$484K 0.17% 97
2018
Q3 		$187K Sell
3,984
-1,113
-22% -$56.5K 0.05% 258
2018
Q2 		$240K Buy
5,097
+1,603
+46% +$80.7K 0.08% 201
2018
Q1 		$158K Buy
3,494
+1,628
+87% +$75.8K 0.06% 296
2017
Q4 		$71K Sell
1,866
-1,771
-49% -$81.8K 0.03% 506
2017
Q3 		$171K Buy
3,637
+161
+5% +$8.17K 0.07% 241
2017
Q2 		$162K Buy
3,476
+118
+4% +$6.29K 0.07% 224
2017
Q1 		$170K Buy
3,358
+1,887
+128% +$95.7K 0.07% 219
2016
Q4 		$63K Sell
1,471
-964
-40% -$47.6K 0.03% 370
2016
Q3 		$122K Buy
2,435
+255
+12% +$14K 0.08% 210
2016
Q2 		$111K Buy
2,180
+130
+6% +$6.85K 0.08% 211
2016
Q1 		$99K Buy
2,050
+1,011
+97% +$50.4K 0.06% 224
2015
Q4 		$48K Buy
1,039
+224
+27% +$11.4K 0.03% 389
2015
Q3 		$37K Buy
815
+3
+0.4% +$156 0.03% 476
2015
Q2 		$41K Buy
+812
New +$45.7K 0.03% 475

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Quadrant Capital Group's GSK Position: Q1 2026 in Review

Quadrant Capital Group increased its GSK (GSK) stake by 2% in Q1 2026, buying an estimated $54.1K and bringing the position to 50,151 shares worth $2.77M. The position accounts for 0.08% of the portfolio, ranked #195.

Quadrant Capital Group first reported a position in GSK in Q2 2015 and has held it in 44 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Quadrant Capital Group held 50,151 shares of GSK worth $2.77M as of Q1 2026.
  • Quadrant Capital Group bought 999 GSK shares in Q1 2026, an estimated $54.1K.
  • GSK made up 0.08% of Quadrant Capital Group's portfolio in Q1 2026, its #195 holding.
  • Quadrant Capital Group first reported a position in GSK in Q2 2015 and has held it in 44 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.